fig10

Study of biological markers in skin quality treatment by subcutaneous injection of a stabilized composition of 26 mg/mL of high molecular weight HA

Figure 10. Collagen type I immunostaining (percentage of interest area covered by the immunostaining) in the dermal layer on Day 8 (D8) after injection. #P < 0.1 (90%) vs. control; ns: non-significative vs. control.

Plastic and Aesthetic Research
ISSN 2349-6150 (Online)   2347-9264 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/